Glide Pharmaceutical Technologies Ltd.
This article was originally published in Start Up
Executive Summary
The UK's Glide Pharma has developed a needle-free, solid-dose drug delivery technology that's easy to use and applicable to both small and large molecules. In essence, tiny solid 'rods' of drug are simply pushed through the skin--no sharps, no blistering, and none of the storage issues associated with some liquid-dosed biologicals.
You may also be interested in...
The Drug Delivery Road Gets Tougher
While making money in drug delivery has always been tougher than its boosters have promised, this year's been ugly in new and disturbing ways. The key lessons of Pfizer's abandonment of inhaled insulin and Impax's patent assault on Endo's Opana are that partners are less reliable; the products need to be medically superior to existing ones, not simply more convenient; and generic companies are making inroads into the main bastion of drug-delivery success -- spec pharma.
Start-Up Previews
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "The Drug Delivery Road Gets Tougher," features profiles of ActoGeniX, Atacama Labs, Glide Pharma and Mimetic Solutions. Plus these Start-Ups Across Health Care: Light Dimensions, Relyspa, Stentys and Thrombotargets.
The Drug Delivery Road Gets Tougher
While making money in drug delivery has always been tougher than its boosters have promised, this year's been ugly in new and disturbing ways. The key lessons of Pfizer's abandonment of inhaled insulin and Impax's patent assault on Endo's Opana are that partners are less reliable; the products need to be medically superior to existing ones, not simply more convenient; and generic companies are making inroads into the main bastion of drug-delivery success -- spec pharma.